$10.30
0.050.49%
At Close: -
$10.30
00.00%
After Hours: Jul 5, 4:01 PM EDT
15 minutes delayed
Phathom Pharmaceuticals
PHATNASDAQ
Phathom Pharmaceuticals (PHAT) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPhathom Pharmaceuticals (NASDAQ:PHAT) Stock Quotes, Forecast and News Summary
Phathom Pharmaceuticals Stock (NASDAQ: PHAT) stock price, news, charts, stock research, profile.
| Open | $10.22 |
| Close | $10.30 |
| Volume / Avg. | 242.97K / 600.84K |
| Day Range | 10.09 - 10.55 |
| 52 Wk Range | 6.07 - 17.02 |
| Market Cap | $602.91M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 46 |
| Short Interest | 45.97% |
| Days to Cover | 32.1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Phathom Pharmaceuticals Inc
Sector
Health Care
Industry
Pharmaceuticals
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focu...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Phathom Pharmaceuticals (PHAT) stock?
You can purchase shares of Phathom Pharmaceuticals (NASDAQ:PHAT) through any online brokerage.
Who are Phathom Pharmaceuticals (PHAT) competitors?
Other companies in Phathom Pharmaceuticals’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and WAVE Life Sciences (NASDAQ:WVE).
What is the target price for Phathom Pharmaceuticals (PHAT) stock?
There is no analysis for Phathom Pharmaceuticals.
What is the forecast for Phathom Pharmaceuticals (PHAT) stock?
Phathom Pharmaceuticals has a consensus price target of $20.56.
Current stock price for Phathom Pharmaceuticals (PHAT)?
The stock price for Phathom Pharmaceuticals (NASDAQ: PHAT) is $10.3 last updated July 5, 2024 at 4:01 PM EDT.
Does Phathom Pharmaceuticals (PHAT) pay a dividend?
There are no upcoming dividends for Phathom Pharmaceuticals.
When is Phathom Pharmaceuticals (NASDAQ:PHAT) reporting earnings?
Phathom Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Phathom Pharmaceuticals (PHAT) going to split?
There is no upcoming split for Phathom Pharmaceuticals.
What sector and industry does Phathom Pharmaceuticals (PHAT) operate in?
Phathom Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.